NCT07702630

Brief Summary

The goal of this observational genetic case-control study is to learn whether two specific genetic variants in ABCG8 and UGT1A1 are associated with gallstone disease after bariatric surgery. The study includes adults who have previously undergone bariatric surgery. The main questions it aims to answer are whether the ABCG8 D19H variant and the UGT1A1 rs6742078 variant are associated with an increased risk of gallstone disease requiring cholecystectomy after bariatric surgery. Researchers will compare patients who underwent bariatric surgery and later had their gallbladder removed because of gallstone disease with patients who underwent bariatric surgery but did not develop gallstone disease or undergo cholecystectomy during follow-up. Participants will provide one blood sample for targeted genetic analysis and complete questionnaires about health, previous surgery, medication use, family history, and gastrointestinal quality of life. Relevant clinical information will also be collected from medical records.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
270

participants targeted

Target at P75+ for all trials

Timeline
29mo left

Started Oct 2026

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 14, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2026

Expected
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2029

2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2029

Last Updated

July 17, 2026

Status Verified

July 1, 2026

Enrollment Period

2.3 years

First QC Date

July 9, 2026

Last Update Submit

July 16, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • ABCG8 carrier status

    The primary outcome is the association between ABCG8 D19H carrier status and gallstone-related cholecystectomy after bariatric surgery. Cases are participants who underwent bariatric surgery and subsequently underwent cholecystectomy due to gallstone disease. Controls are participants who underwent bariatric surgery and did not undergo cholecystectomy or develop gallstone disease during follow-up. The association will be estimated by comparing genotype frequencies between cases and controls.

    3 years

Secondary Outcomes (1)

  • Association Between UGT1A1 rs6742078 Carrier Status and Gallstone-Related Cholecystectomy After Bariatric Surgery

    3 years

Study Arms (2)

Bariatric surgery and subsequently cholecystectomy for gallstone disease

The case group. 135 patients.

Diagnostic Test: blood sampling

Bariatric surgery and no gallstone disease

Control group. A minimum of 5 years of follow up after bariatric surgery.

Diagnostic Test: blood sampling

Interventions

blood samplingDIAGNOSTIC_TEST

Targeted genetic analysis of the ABCG8 D19H variant and the UGT1A1 rs6742078 variant using a blood sample.

Bariatric surgery and no gallstone diseaseBariatric surgery and subsequently cholecystectomy for gallstone disease

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults who previously underwent bariatric surgery in the Region of Southern Denmark will be included. The study population consists of two groups: cases and controls. Cases are patients who underwent bariatric surgery and subsequently underwent cholecystectomy due to gallstone disease. Controls are patients who underwent bariatric surgery and have had at least five years of follow-up without registered gallstone disease or cholecystectomy. All participants will be identified through hospital records in the Region of Southern Denmark. Participants will provide a blood sample for targeted genetic analysis of selected variants in ABCG8 and UGT1A1 and complete questionnaires on health, medication use, family history, and gastrointestinal quality of life.

You may qualify if:

  • Bariatric surgery

You may not qualify if:

  • Gallstone disease or cholecystectomy prior to bariatric surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cholelithiasis

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Biliary Tract DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D., PhD Fellow

Study Record Dates

First Submitted

July 9, 2026

First Posted

July 14, 2026

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

January 1, 2029

Study Completion (Estimated)

March 1, 2029

Last Updated

July 17, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Small study. Individual participant data will not be shared due to the sensitive nature of genetic and clinical data and restrictions under Danish data protection regulations. Aggregated results can be shared in publications and upon reasonable request, where legally and ethically permissible.